3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
54
Lung Neoplasms
22
Neoplasms
4
Neoplasm Metastasis
3
Carcinoma
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Stage IB-IIIA Non-small Cell Lung Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
1
Non Small Cell Lung Cancer Metastatic
1
NSCLC
1
Multiple Endocrine Neoplasia Type 2a
1
Mesothelioma
1
Interventions
Etoposide
31
Carboplatin
30
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
PM 01183
11
Specimen Handling
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
7
olaparib
5
Radiotherapy
5
berzosertib
4
anlotinib
4
Paclitaxel
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Temozolomide
3
Radiosurgery
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
osimertinib
×
90 days
×
Clear all
No trials found.